FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 333:389-390 August 10, 1995 Number 6 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Thompson, S. G. PubMed Citation

To the Editor: On the basis of a two-year follow-up, Thompson et al. (March 9 issue)¹ conducted a prospective study to evaluate the influence of hemostatic factors on cardiovascular risk. The authors report that patients with high cholesterol levels but low fibrinogen levels had a low risk of coronary events. They conclude that the fibrinogen level can be used to identify patients with hypercholesterolemia who are at particularly high risk for coronary events.

We think that an important factor has not been considered in this conclusion. The concentration of high-density lipoprotein (HDL) cholesterol is known to be inversely correlated with . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Schieffer, B. (2003). Interaction of interleukin-6 and angiotensin II in atherosclerosis: culprit for inflammation?. Eur Heart J Suppl 5: A25-A30 [Abstract]  
• Sykes, T C F, Fegan, C, Mosquera, D (2000). Thrombophilia, polymorphisms, and vascular disease. Mol. Pathol. 53: 300-306 [Abstract] [Full Text]  
• Thogersen, A. M., Jansson, J.-H., Boman, K., Nilsson, T. K., Weinehall, L., Huhtasaari, F., Hallmans, G. (1998). High Plasminogen Activator Inhibitor and Tissue Plasminogen Activator Levels in Plasma Precede a First Acute Myocardial Infarction in Both Men and Women : Evidence for the Fibrinolytic System as an Independent Primary Risk Factor. Circulation 98: 2241-2247 [Abstract] [Full Text]  
• van der Bom, J. G., de Knijff, P., Haverkate, F., Bots, M. L., Meijer, P., de Jong, P. T. V. M., Hofman, A., Kluft, C., Grobbee, D. E. (1997). Tissue Plasminogen Activator and Risk of Myocardial Infarction: The Rotterdam Study. Circulation 95: 2623-2627 [Abstract] [Full Text]